Finance

Lists
Why is 603259 down 6,60%?
Dive Deeper
603259:SHA
WuXi AppTec Co Ltd
CN¥144,30
-6,60%
(-10,20) 1D
16 ຕ.ລ., 15 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603259...
Open
CN¥156,94
High
CN¥159,92
Low
CN¥139,05
Mkt. cap
484,94 ຕື້
Avg. vol.
34,02 ລ້ານ
Volume
83,61 ລ້ານ
Dividend
1,45%
Quarterly dividend
CN¥0,52
Ex-dividend date
4 ກ.ຍ. 2026
P/E ratio
19,63
52-wk high
CN¥173,60
52-wk low
CN¥87,09
EPS
CN¥7,35
Shares outstanding
1,05 ຕື້
No. of employees
36 ພັນ
Open
CN¥156,94
High
CN¥159,92
Low
CN¥139,05
Mkt. cap
484,94 ຕື້
Avg. vol.
34,02 ລ້ານ
Volume
83,61 ລ້ານ
Dividend
1,45%
Quarterly dividend
CN¥0,52
Ex-dividend date
4 ກ.ຍ. 2026
P/E ratio
19,63
52-wk high
CN¥173,60
52-wk low
CN¥87,09
EPS
CN¥7,35
Shares outstanding
1,05 ຕື້
No. of employees
36 ພັນ
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
17 ຊົ່ວໂມງກ່ອນ
Morgan Stanley keeps target for WuXi AppTec stock at HKD 207.40
ad-hoc-news.de
ad-hoc-news.de
·
2 ມື້ກ່ອນ
Huaxi Securities maintains Buy for WuXi AppTec stock
Profile
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe. Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
About WuXi AppTec Co Ltd
CEOSteve Yang | Ge Li
Employees35,6 ພັນ
Founded1 ທ.ວ. 2000
Headquarters-
SectorHealth care
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
12,04 ຕື້
10,97 ຕື້
12,44 ຕື້
16,46 ຕື້
Cost of goods sold
6,07 ຕື້
4,91 ຕື້
6,17 ຕື້
-
Cost of revenue
6,07 ຕື້
4,91 ຕື້
6,17 ຕື້
-
Research and development expenses
311,73 ລ້ານ
236,94 ລ້ານ
266,96 ລ້ານ
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
854,49 ລ້ານ
853,67 ລ້ານ
891,80 ລ້ານ
-
Operating expense
1,38 ຕື້
1,26 ຕື້
1,22 ຕື້
-
Total operating expenses
7,45 ຕື້
6,17 ຕື້
7,39 ຕື້
-
Operating income
4,59 ຕື້
4,80 ຕື້
5,04 ຕື້
-
Other non operating income
-470,36 ລ້ານ
281,37 ລ້ານ
-266,37 ລ້ານ
-
EBT including unusual items
5,13 ຕື້
6,75 ຕື້
5,61 ຕື້
-
EBT excluding unusual items
5,11 ຕື້
6,95 ຕື້
5,19 ຕື້
-
Income tax expense
1,55 ຕື້
1,09 ຕື້
936,77 ລ້ານ
-
Effective tax rate
30,19%
16,12%
16,71%
-
Other operating expenses
57,96 ລ້ານ
25,84 ລ້ານ
726,05 ພັນ
-
Net income
3,51 ຕື້
7,08 ຕື້
4,65 ຕື້
-
Net profit margin
29,18%
64,49%
37,40%
-
Earnings per share
1,24
1,42
1,57
2,20
Interest and investment income
1,21 ຕື້
1,87 ຕື້
439,82 ລ້ານ
-
Interest expense
-226,71 ລ້ານ
-
-30,95 ລ້ານ
-
Net interest expenses
981,72 ລ້ານ
1,87 ຕື້
408,87 ລ້ານ
-
Depreciation and amortization charges
-
-
-
-
EBITDA
5,21 ຕື້
5,61 ຕື້
5,85 ຕື້
-
Gain or loss from assets sale
-158,03 ລ້ານ
218,40 ລ້ານ
-
-
AI content may include mistakes. Learn more
ແອັບຂອງ Google